From: UA Cancer Center News Release
The University of Arizona Early Phase Chemoprevention Consortium led by UA Cancer Center researchers has been awarded $9.6 million over five years by the National Cancer Institute to conduct early-phase clinical trials to evaluate the safety, clinical activity, and biological effects of novel cancer preventive agents.
Read More: UA Cancer Center awarded $9.6 million for studies